(Q48214910)

9 February 2018

title

Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures (English)

1 reference

9 February 2018

author name string

Beffert U

1

1 reference

9 February 2018

Aumont N

2

1 reference

9 February 2018

Dea D

3

1 reference

9 February 2018

Lussier-Cacan S

4

1 reference

9 February 2018

Davignon J

5

1 reference

9 February 2018

Poirier J

6

1 reference

9 February 2018

publication date

1 May 1999

1 reference

9 February 2018

published in

Molecular Brain Research

1 reference

9 February 2018

volume

68

1 reference

9 February 2018

issue

1-2

1 reference

9 February 2018

page(s)

181-185

1 reference

9 February 2018

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Expression of apolipoprotein E mRNA in rat microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Apolipoprotein E polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Normal and abnormal biology of the beta-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Localization of mRNA for low density lipoprotein receptor and a cholesterol synthetic enzyme in rabbit nervous system by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2899%2900073-X

7 January 2021

10.1016/S0169-328X(99)00073-X

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018